These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


249 related items for PubMed ID: 8158701

  • 21. 4-Aminobiphenyl hemoglobin adducts in fetuses exposed to the tobacco smoke carcinogen in utero.
    Coghlin J, Gann PH, Hammond SK, Skipper PL, Taghizadeh K, Paul M, Tannenbaum SR.
    J Natl Cancer Inst; 1991 Feb 20; 83(4):274-80. PubMed ID: 1994056
    [Abstract] [Full Text] [Related]

  • 22. Elevated 4-aminobiphenyl and 2,6-dimethylaniline hemoglobin adducts and increased risk of bladder cancer among lifelong nonsmokers--The Shanghai Bladder Cancer Study.
    Tao L, Day BW, Hu B, Xiang YB, Wang R, Stern MC, Gago-Dominguez M, Cortessis VK, Conti DV, Van Den Berg D, Pike MC, Gao YT, Yu MC, Yuan JM.
    Cancer Epidemiol Biomarkers Prev; 2013 May 20; 22(5):937-45. PubMed ID: 23539508
    [Abstract] [Full Text] [Related]

  • 23. Tissue distribution of N-acetyltransferase 1 and 2 catalyzing the N-acetylation of 4-aminobiphenyl and O-acetylation of N-hydroxy-4-aminobiphenyl in the congenic rapid and slow acetylator Syrian hamster.
    Hein DW, Doll MA, Nerland DE, Fretland AJ.
    Mol Carcinog; 2006 Apr 20; 45(4):230-8. PubMed ID: 16482518
    [Abstract] [Full Text] [Related]

  • 24. Gender- and smoking-related bladder cancer risk.
    Castelao JE, Yuan JM, Skipper PL, Tannenbaum SR, Gago-Dominguez M, Crowder JS, Ross RK, Yu MC.
    J Natl Cancer Inst; 2001 Apr 04; 93(7):538-45. PubMed ID: 11287448
    [Abstract] [Full Text] [Related]

  • 25. Comparison of CYP1A2 and NAT2 phenotypes between black and white smokers.
    Muscat JE, Pittman B, Kleinman W, Lazarus P, Stellman SD, Richie JP.
    Biochem Pharmacol; 2008 Oct 01; 76(7):929-37. PubMed ID: 18703023
    [Abstract] [Full Text] [Related]

  • 26. DNA adducts, protein adducts, and sister chromatid exchange in cigarette smokers and nonsmokers.
    Perera FP, Santella RM, Brenner D, Poirier MC, Munshi AA, Fischman HK, Van Ryzin J.
    J Natl Cancer Inst; 1987 Sep 01; 79(3):449-56. PubMed ID: 3114532
    [Abstract] [Full Text] [Related]

  • 27. Biomonitoring of smoke constituents: exposure to 4-aminobiphenyl and 4-aminobiphenyl hemoglobin adduct levels in nonsmokers and smokers.
    Schorp MK, Leyden DE.
    Inhal Toxicol; 2010 Aug 01; 22(9):725-37. PubMed ID: 20433335
    [Abstract] [Full Text] [Related]

  • 28. Haemoglobin adducts of aromatic amines in people exposed to cigarette smoke.
    Bryant MS, Vineis P, Skipper PL, Tannenbaum SR.
    IARC Sci Publ; 1988 Aug 01; (89):133-6. PubMed ID: 3198197
    [Abstract] [Full Text] [Related]

  • 29. Metabolic activation of N-hydroxy-2-aminofluorene and N-hydroxy-2-acetylaminofluorene by monomorphic N-acetyltransferase (NAT1) and polymorphic N-acetyltransferase (NAT2) in colon cytosols of Syrian hamsters congenic at the NAT2 locus.
    Hein DW, Doll MA, Gray K, Rustan TD, Ferguson RJ.
    Cancer Res; 1993 Feb 01; 53(3):509-14. PubMed ID: 8425184
    [Abstract] [Full Text] [Related]

  • 30. Quantification of Hemoglobin and White Blood Cell DNA Adducts of the Tobacco Carcinogens 2-Amino-9H-pyrido[2,3-b]indole and 4-Aminobiphenyl Formed in Humans by Nanoflow Liquid Chromatography/Ion Trap Multistage Mass Spectrometry.
    Cai T, Bellamri M, Ming X, Koh WP, Yu MC, Turesky RJ.
    Chem Res Toxicol; 2017 Jun 19; 30(6):1333-1343. PubMed ID: 28493705
    [Abstract] [Full Text] [Related]

  • 31. Modulation of DNA and protein adducts in smokers by genetic polymorphisms in GSTM1,GSTT1, NAT1 and NAT2.
    Godschalk RW, Dallinga JW, Wikman H, Risch A, Kleinjans JC, Bartsch H, Van Schooten FJ.
    Pharmacogenetics; 2001 Jul 19; 11(5):389-98. PubMed ID: 11470992
    [Abstract] [Full Text] [Related]

  • 32. The use of 4-aminobiphenyl hemoglobin adducts and aromatic DNA adducts in lymphocytes of smokers as biomarkers of exposure.
    Dallinga JW, Pachen DM, Wijnhoven SW, Breedijk A, van 't Veer L, Wigbout G, van Zandwijk N, Maas LM, van Agen E, Kleinjans JC, van Schooten FJ.
    Cancer Epidemiol Biomarkers Prev; 1998 Jul 19; 7(7):571-7. PubMed ID: 9681524
    [Abstract] [Full Text] [Related]

  • 33. Polymorphic expression of acetyl coenzyme A-dependent arylamine N-acetyltransferase and acetyl coenzyme A-dependent O-acetyltransferase-mediated activation of N-hydroxyarylamines by human bladder cytosol.
    Kirlin WG, Trinidad A, Yerokun T, Ogolla F, Ferguson RJ, Andrews AF, Brady PK, Hein DW.
    Cancer Res; 1989 May 01; 49(9):2448-54. PubMed ID: 2784998
    [Abstract] [Full Text] [Related]

  • 34. Hemoglobin adducts of 4-aminobiphenyl in smokers and nonsmokers.
    Bryant MS, Skipper PL, Tannenbaum SR, Maclure M.
    Cancer Res; 1987 Jan 15; 47(2):602-8. PubMed ID: 3791245
    [Abstract] [Full Text] [Related]

  • 35. Aromatic amine DNA adduct formation in chronically-exposed mice: considerations for human comparison.
    Poirier MC, Beland FA.
    Mutat Res; 1997 May 12; 376(1-2):177-84. PubMed ID: 9202754
    [Abstract] [Full Text] [Related]

  • 36. Analysis of 4-aminobiphenyl hemoglobin adducts in smokers and nonsmokers by pseudo capillary on-column gas chromatography- tandem mass spectrometry.
    Seyler TH, Reyes LR, Bernert JT.
    J Anal Toxicol; 2010 May 12; 34(6):304-11. PubMed ID: 20663282
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. 4-Aminobiphenyl downregulation of NAT2 acetylator genotype-dependent N- and O-acetylation of aromatic and heterocyclic amine carcinogens in primary mammary epithelial cell cultures from rapid and slow acetylator rats.
    Jefferson FA, Xiao GH, Hein DW.
    Toxicol Sci; 2009 Jan 12; 107(1):293-7. PubMed ID: 18842621
    [Abstract] [Full Text] [Related]

  • 39. Effects of N-acetyl transferase 1 and 2 polymorphisms on bladder cancer risk in Caucasians.
    Gu J, Liang D, Wang Y, Lu C, Wu X.
    Mutat Res; 2005 Mar 07; 581(1-2):97-104. PubMed ID: 15725609
    [Abstract] [Full Text] [Related]

  • 40. Analysis of DNA adducts in smokers' lung and urothelium by 32P-postlabelling: metabolic phenotype dependence and comparisons with other exposure markers.
    Bartsch H, Castegnaro M, Camus AM, Schouft A, Geneste O, Rojas M, Alexandrov K.
    IARC Sci Publ; 1993 Mar 07; (124):331-40. PubMed ID: 8225503
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 13.